ERBB2 and inflammatory breast carcinoma: SUM190PT cell line is derived from ER- and PR (progesterone)-negative primary IBC and characterized for having TP53 p.Gln317Ter (c.949C>T) variant, HER2 overexpression, and BRCA1 wild type [150].